Patents by Inventor Mark Mellencamp

Mark Mellencamp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Potomac horse fever isolates
    Patent number: 9764017
    Abstract: The present invention discloses novel isolates of Neorickettsia risticii, compositions comprising such isolates, vaccines and methods for using such vaccines against Potomac Horse Fever.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: September 19, 2017
    Assignee: Intervet Inc.
    Inventors: Lisa Purtle, Mark Mellencamp, Wendy Vaala
  • Potomac Horse Fever Isolates
    Publication number: 20160206720
    Abstract: The present invention discloses novel isolates of Neorickettsia risticii, compositions comprising such isolates, vaccines and methods for using such vaccines against Potomac Horse Fever.
    Type: Application
    Filed: April 8, 2016
    Publication date: July 21, 2016
    Applicant: Intervet Inc.
    Inventors: Lisa Purtle, Mark Mellencamp, Wendy Vaala
  • Potomac horse fever isolates
    Patent number: 9339532
    Abstract: The present invention discloses novel isolates of Neorickettsia risticii, compositions comprising such isolates, vaccines and methods for using such vaccines against Potomac Horse Fever.
    Type: Grant
    Filed: December 10, 2013
    Date of Patent: May 17, 2016
    Assignee: Intervet Inc.
    Inventors: Lisa Purtle, Mark Mellencamp, Wendy Vaala
  • POTOMAC HORSE FEVER ISOLATES
    Publication number: 20140186385
    Abstract: The present invention discloses novel isolates of Neorickettsia risticii, compositions comprising such isolates, vaccines and methods for using such vaccines against Potomac Horse Fever.
    Type: Application
    Filed: December 10, 2013
    Publication date: July 3, 2014
    Applicant: Intervet Inc.
    Inventors: Lisa Purtle, Mark Mellencamp, Wendy Vaala
  • Potomac horse fever isolates
    Patent number: 8628947
    Abstract: The present invention discloses novel isolates of Neorickettsia risticii, compositions comprising such isolates, vaccines and methods for using such vaccines against Potomac Horse Fever.
    Type: Grant
    Filed: August 30, 2011
    Date of Patent: January 14, 2014
    Assignee: Intervet Inc.
    Inventors: Lisa Purtle, Mark Mellencamp, Wendy Vaala
  • POTOMAC HORSE FEVER ISOLATES
    Publication number: 20120052091
    Abstract: The present invention discloses novel isolates of Neorickettsia risticii, compositions comprising such isolates, vaccines and methods for using such vaccines against Potomac Horse Fever.
    Type: Application
    Filed: August 30, 2011
    Publication date: March 1, 2012
    Inventors: Lisa PURTLE, Mark Mellencamp, Wendy Vaala
  • Equine herpesvirus vaccine
    Publication number: 20070196390
    Abstract: A vaccine for protecting a horse against diseases associated with EHV-1 and/or EHV-4 is provided. The vaccine commonly includes inactivated EHV-1 (e.g., chemically inactivated EHV-1 KyA virus) and an adjuvant. The adjuvant can include a cross-linked olefinically unsaturated carboxylic acid polymer which may have bioadhesive properties. The vaccine may also include antigens against other equine pathogens such as inactivated EHV-4 and inactivated A1 and/or A2 strains of equine influenza virus. Methods for protecting horses against diseases associated with EHV-1 and/or EHV-4 and methods of producing the equine herpesvirus vaccine are also provided.
    Type: Application
    Filed: April 26, 2007
    Publication date: August 23, 2007
    Inventor: Mark Mellencamp
  • Inactivated chimeric and related methods of use
    Publication number: 20070009548
    Abstract: Embodiments of the present invention generally provide an inactivated chimeric virus vaccine and/or immunogenic composition for the treatment or prevention of viral infection. Further, various other embodiments of the present invention generally relate to methods of preventing and treating virus infection in such animals with the inactivated vaccine and/or immunogenic composition. Other embodiments comprise methods of preparing a vaccine or immunogenic composition for the treatment or prevention of viral infection in such animals.
    Type: Application
    Filed: June 23, 2006
    Publication date: January 11, 2007
    Inventors: Frank Sterner, Daniel Goovaerts, Melissa Lum, Mark Mellencamp
  • Equine herpesvirus vaccine
    Publication number: 20050084502
    Abstract: A vaccine for protecting a horse against diseases associated with EHV-1 and/or EHV-4 is provided. The vaccine commonly includes inactivated EHV-1 (e.g., chemically inactivated EHV-1 KyA virus) and an adjuvant. The adjuvant can include a cross-linked olefinically unsaturated carboxylic acid polymer which may have bioadhesive properties. The vaccine may also include antigens against other equine pathogens such as inactivated EHV-4 and inactivated A1 and/or A2 strains of equine influenza virus. Methods for protecting horses against diseases associated with EHV-1 and/or EHV-4 and methods of producing the equine herpesvirus vaccine are also provided.
    Type: Application
    Filed: July 23, 2004
    Publication date: April 21, 2005
    Inventor: Mark Mellencamp